Vascular Mechanisms, Functional Outcomes, & Exercise Among Persons With Multiple Sclerosis With Hypertension
Launched by UNIVERSITY OF MASSACHUSETTS, BOSTON · Aug 12, 2024
Trial Information
Current as of September 07, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a 12-week home-based cycling exercise program can help improve blood pressure, thinking skills, and walking ability in people with multiple sclerosis (MS) who also have high blood pressure. Participants will be randomly assigned to either the cycling program or a stretching program, allowing researchers to compare the effects of both activities. The trial aims to see if cycling can help blood vessels work better, which might lead to improvements in both physical and mental health.
To participate, individuals must have a confirmed diagnosis of MS and be between 65 and 74 years old. They should also have high blood pressure and be physically inactive, meaning they exercise less than an hour a week. Participants will need to visit the lab twice—once before starting the program and once after it ends—to complete tests related to their blood pressure, walking ability, and thinking skills. This study will last about 13-14 weeks, and those interested should ensure they meet the eligibility criteria and are not dealing with other serious health issues that could affect their participation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Persons with confirmed multiple sclerosis diagnosis with Expanded Disability Status Scale scores of 4-6.5, characteristic of 2nd stage of multiple sclerosis;
- • Hypertension defined as elevated, or Stage 1 or 2, as per the 2017 American Heart Association guidelines (brachial systolic blood pressure \> 120 mmHg or brachial diastolic blood pressure \> 80 mmHg)
- • Persons who are physically inactive (less than 60 min/wk of physical activity);
- • Persons with body mass index \< 40 kg/m2;
- • Persons who are not confined to a wheel chair;
- • Multiple sclerosis relapse in the past 30 days;
- • People with stable pharmacotherapy.
- Exclusion Criteria:
- • People with additional cardiovascular comorbidities;
- • People with type 1 diabetes mellitus;
- • Physician disapproval to participating in the study;
- • Space constraints to fit a cycle ergometer at the home of prospective participants.
About University Of Massachusetts, Boston
The University of Massachusetts, Boston, is a leading academic institution dedicated to advancing healthcare research and innovation. As a prominent sponsor of clinical trials, the university leverages its extensive resources, expert faculty, and collaborative environment to explore new medical therapies and interventions. Committed to improving public health outcomes, UMass Boston fosters rigorous scientific inquiry and ethical standards in its research endeavors, aiming to translate findings into practical applications that benefit diverse populations. Through partnerships with healthcare providers and community organizations, the university plays a vital role in addressing critical health challenges and enhancing the quality of care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Bo Fernhall, PhD
Principal Investigator
University of Massachusetts, Boston
Tracy Baynard, PhD
Principal Investigator
University of Massachusetts, Boston
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported